Amman: Jordan Food and Drug Administration (JFDA) underlined the importance of administering intravenous iron infusions under medical supervision to ensure "correct" dosage and prevent potential health complications, primarily allergic reactions that may require emergency procedures due to the rare but serious risk to life. In a statement issued Sunday, the JFDA detailed that allergic reactions can surface as mild symptoms, mainly skin rash, itching, redness, a feeling of warmth or tingling, slight swelling in the face or hands, shortness of breath or wheezing, while the acute symptoms can involve anaphylactic shock, mainly severe difficulty in breathing, rapid or irregular heartbeat, and significant drops in blood pressure. The JFDA advised people, who suffered these symptoms after receiving an iron infusion, should immediately seek medical attention at the nearest hospital or emergency center. Source: Jordan News Agency
JFDA Advises Medical Supervision for Iron infusions to Avoid Health Risks
Recent Posts
FNC Participates in Geneva Conference on Human Rights
November 13, 2026
Ajman Transport and Ajman Club Sign MoU to Enhance Strategic Partnership
November 13, 2026
UAE Strengthens Economic Ties with India at 31st CII Partnership Summit
November 13, 2026